Table 2

Seroprevalence by demographic characteristics

Participants tested, nSeropositive participants, nUnweighted seroprevalence, %
(95% CI)
Weighted seroprevalence, %
(95% CI)*
Overall1893532.8 (2.1 to 3.5)2.6 (1.9 to 3.4)
Age, years
<1034051.5 (0.5 to 3.4)1.7 (0.2 to 3.2)
10–1938492.3 (1.1 to 4.4)2.6 (0.8 to 4.2)
20–3945161.3 (0.5 to 2.9)1.2 (0.2 to 2.3)
40–59359195.3 (3.2 to 8.1)4.4 (2.4 to 6.4)
>60359143.9 (2.1 to 6.5)3.6 (1.6 to 5.6)
Rao-Scott
Χ2 p value
0.00320.0548
Gender
Female964333.4 (2.4 to 4.8)3.3 (2.2 to 4.5)
Male929202.2 (1.3 to 3.3)1.9 (1.0 to 2.8)
Rao-Scott
Χ2 p value
0.09390.0563
Area of residence
Rural1174242.0 (1.3 to 3.0)1.8 (1.0 to 2.5)
Urban719294.0 (2.7 to 5.7)4.2 (2.6 to 5.7)
Rao-Scott
Χ2 p value
0.01090.0023
  • *Post-stratified by district.